Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride | - |
Homo sapiens | |
specific Cat-G inhibitor | 1 microM, decrease of enzyme activity by 43% | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
39000 | - |
Western blot | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
colon | - |
Homo sapiens | - |
feces | - |
Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
15% cathepsin G acitivity among total proteolytic activity of fecal supernatants, in patients with ulcerative colitits | Homo sapiens |
additional information | - |
7% cathepsin G acitivity among total proteolytic activity of fecal supernatants, in healthy patients | Homo sapiens |
2.02 | - |
healthy subjects | Homo sapiens |
16.14 | - |
patients with ulcerative colitis and specific Cat-G inhibitor | Homo sapiens |
28.34 | - |
patients with ulcerative colitis | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide + H2O | assay at 37°C | Homo sapiens | N-succinyl-Ala-Ala-Pro-Phe + p-nitroaniline | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Cat-G | - |
Homo sapiens |
cathepsin G | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | higher expression of Cat-G in biopsies from patients with ulcerative colitis | up |